CLINICAL_TRIALS
trial_result
· 2014-09-25
Clinical Trial Update: Effect of LY450139 on the Long Term Progression of Alzheimer's Disease [Phase 3]
Summary
Phase 3 trial of LY450139 (semagacestat) for Alzheimer's disease has completed; results were posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Alzheimer's Disease | Phase 3 | Status: COMPLETED | Results posted: 2014-09-25